Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 143.00
Bid: 143.00
Ask: 145.00
Change: 0.75 (0.53%)
Spread: 2.00 (1.399%)
Open: 143.00
High: 143.00
Low: 143.00
Prev. Close: 142.25
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on forensic review and remedial action plan

13 Dec 2016 15:07

RNS Number : 7479R
Redcentric PLC
13 December 2016
 

 

13 December 2016

Redcentric plc

("Redcentric" or the "Company")

 

Update on forensic review and remedial action plan

 

Redcentric (AIM:RCN) provides the following update on the progress made with its forensic review previously announced on 7 November 2016.

 

Initial findings from the forensic review 

 

As previously announced, following an internal review by the Company's audit committee in relation to the interim results for the six months ended 30 September 2016, misstated accounting balances in the Group's balance sheet were discovered. Redcentric promptly appointed Deloitte LLP ("Deloitte") and Nabarro LLP ("Nabarro") to carry out an independent forensic review.

 

The forensic review and management's initial findings are as follows.

 

• Net assets impairment: The cumulative overstatement of net assets and profits after tax up to 30 September 2016 is approximately £20.8 million. The current position is that approximately £5.9 million of this misstatement (£4.7 million at the EBITDA level) arose in the six months ended 30 September 2016 and will be reflected in the Company's interim results when they are published this month. The remaining £14.9 million misstatement relates to periods prior to and including the year ended 31 March 2016. To date there has been no evidence of theft and the misstatements are attributable to profit overstatement over a number of years with revenues being overstated and costs understated in broadly equal proportions.

 

• Net debt: As previously reported, the net debt position for both 31 March 2016 and 30 September 2016 is materially higher than originally reported. As at 31 March 2016, net debt was £37.8 million and as at 30 September 2016 net debt was £34.4 million.

 

However, the net debt position as at the period ends mentioned above are not representative because creditors had been significantly stretched at those dates. The average month end net debt position over the past eight months to 30 November 2016 was £42.0 million. This is expected to reduce as billing and debtor collection processes are improved.

 

Banking covenants

  

As noted in the announcement on 7 November 2016, the Company has recalculated its historic banking covenants due to the impact of various accounting adjustments. The Company is pleased to report that it has secured waivers from its Banks in relation to historic covenants such that it is fully compliant with its facilities. The Banks remain supportive of Redcentric and constructive discussions are ongoing in relation to the agreement of future covenant levels which reflect management's business plan.

 

Remedial action plan

 

As well as promptly appointing Deloitte and Nabarro to carry out the independent forensic review, management have also prepared and are executing a remedial plan of action.

 

Some important first steps have been made. These include the appointment of Peter Brotherton as Chief Financial Officer and Julian Llewellyn as Interim CFO. Both are based at Redcentric's headquarters in Harrogate. A full review of the entire finance function is underway, being directly led by Peter Brotherton.

 

A number of initial improvements have already been made including changes to billing and credit control management systems and processes. The restructuring of the finance function will continue as necessary.

 

Interim results announcement and outlook

 

The Company will report its interim results before 31 December 2016.

 

The Company currently expects to report for the six months ended 30 September 2016 revenue of approximately £53.0 million and EBITDA* of approximately £9.1 million. Given the recurrent nature of a majority of the Group's revenue, being in excess of 80% of total Group revenue, the Board believes that this performance is indicative of the performance for the second half of the year. The sales pipeline remains strong at approximately £93.0 million and the H1 sales targets were exceeded, incorporating 38 new client wins.

 

Given the increase in the Company's net debt position, the Board has resolved not to declare an interim dividend. With an anticipated improvement in net debt, the Board will review the Company's dividend policy at the time of the full-year results.

 

The Company has been very encouraged and appreciative of the supportive response from its employees, clients and prospective clients. The Company is focused on completing the matters outstanding in response to the forensic review, reporting the interim results and engaging with our valued clients and staff.

 

This announcement contains inside information.

 

 Enquiries:

 

Redcentric plc

via Tulchan Communications

Fraser Fisher, Chief Executive Officer

 

Peter Brotherton, Chief Financial Officer

 

 

 

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

 

 

 

Numis Securities Limited - Nomad & Joint Broker

+44 (0)20 7260 1000

Simon Willis / Ben Stoop / Oliver Hardy

 

 

 

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

 

 

* Earnings before interest, tax, depreciation, amortisation of acquired intangibles, transaction and integration costs and share based payments.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFIEFELVLIR
Date   Source Headline
20th Aug 201911:00 amRNSDirectorate Change
14th Aug 20197:00 amRNSExercise of Options
2nd Aug 20197:00 amRNSPublication of Annual Report and Notice of AGM
17th Jul 20193:48 pmRNSDividend Dates
17th Jul 20197:00 amRNSChange of Dividend Dates
1st Jul 20193:58 pmRNSIssue of Options
25th Jun 20197:00 amRNSPreliminary Results Announcement FY19
28th May 20197:00 amRNSDirectorate Change
15th Apr 20197:00 amRNSTrading update and notice of results date
26th Feb 20192:58 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSDirectorate Change
5th Dec 20184:01 pmRNSDirector/PDMR Shareholding
28th Nov 20183:12 pmRNSHolding(s) in Company
27th Nov 20183:31 pmRNSHolding(s) in Company
22nd Nov 20187:01 amRNSDirectorate Change
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:00 pmRNSHolding(s) in Company
4th Oct 20187:00 amRNSPre-Close Statement
3rd Sep 20186:05 pmRNSResult of AGM
9th Aug 201811:52 amRNSPublication of Annual Report and Notice of AGM
13th Jul 201810:14 amRNSHolding(s) in Company
12th Jul 20185:01 pmRNSHolding(s) in Company
5th Jul 20182:45 pmRNSHolding(s) in Company
28th Jun 20187:00 amRNSPreliminary Results Announcement FY18
26th Jun 20185:03 pmRNSHolding(s) in Company
8th Jun 20182:50 pmRNSTrading update
26th Apr 20187:00 amRNSAward of public sector framework agreement
19th Apr 20187:00 amRNSTrading Statement
3rd Apr 20183:32 pmRNSHolding(s) in Company
16th Mar 201812:29 pmRNSHolding(s) in Company
16th Mar 201812:28 pmRNSHolding(s) in Company
13th Mar 201812:55 pmRNSHolding(s) in Company
13th Mar 201812:49 pmRNSHolding(s) in Company
12th Mar 20182:10 pmRNSHolding(s) in Company
2nd Mar 201811:45 amRNSHolding(s) in Company
2nd Mar 201810:01 amRNSHolding(s) in Company
28th Feb 201812:40 pmRNSHolding(s) in Company
21st Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSDirectorate Change
23rd Jan 20188:16 amRNSHolding(s) in Company
23rd Jan 20187:00 amRNSExercise of Options
28th Dec 201711:09 amRNSHolding(s) in Company
4th Dec 20177:00 amRNSIssue of Options
29th Nov 20177:00 amRNSHalf Year Results
24th Nov 20179:37 amRNSHolding(s) in Company
31st Oct 20175:52 pmRNSHolding(s) in Company
31st Oct 20175:51 pmRNSHolding(s) in Company
20th Oct 20177:00 amRNSDirectorate Change
5th Oct 20177:00 amRNSAppointment of CEO and Trading Update
21st Sep 20176:06 pmRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.